MedTrace Logo

the Beijing Randomized Study Of Prostate Cancer Screening

NCT05961514 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30000

Last updated 2023-11-02

No results posted yet for this study

Summary

BROPCS is a randomized trial study comparing the effectiveness of traditional systematic biopsies and bpMRI followed targeted biopsies with PSA \> 4ng/ml in initial screening.

Conditions

Interventions

DIAGNOSTIC_TEST

Target biopsies

MRI/Fusion target biopsies combine magnetic resonance imaging (MRI) with ultrasound-guided biopsy techniques to obtain tissue samples from areas of the prostate gland that appear abnormal on MRI.

DIAGNOSTIC_TEST

systemic biopsies

transrectal ultrasound (TRUS) guided prostate systemic biopsies

Sponsors & Collaborators

  • Peking University Cancer Hospital & Institute

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
60 Years
Max Age
75 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-10-31
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05961514 on ClinicalTrials.gov